Fabino Enterprises Ltd vs Phaarmasia Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 05, 2026

Key Highlights

The Latest Trading Price of Fabino Enterprises Ltd is ₹ 20.31 as of 27 Apr 15:30 . The P/E Ratio of Fabino Enterprises Ltd is 600 as of March 2023 .The P/E Ratio of Phaarmasia Ltd is 0 as of March 2023 . The Market Cap of Fabino Enterprises Ltd is ₹ 6.3 crore as of March 2023 .The Market Cap of Phaarmasia Ltd is ₹ 0 crore as of March 2023 . The revenue of Fabino Enterprises Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Phaarmasia Ltd for the Dec '25 is ₹ 35.21 crore as compare to the Sep '25 revenue of ₹ 16.69 crore. This represent the growth of 110.96% The ebitda of Fabino Enterprises Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Phaarmasia Ltd for the Dec '25 is ₹ 19.99 crore as compare to the Sep '25 ebitda of ₹ 1.75 crore. This represent the growth of 1042% The net profit of Fabino Enterprises Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Phaarmasia Ltd changed from ₹ 0.28 crore to ₹ 16.27 crore over 7 quarters. This represents a CAGR of 918.90% The Dividend Payout of Fabino Enterprises Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Phaarmasia Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Fabino Enterprises Ltd

Fabino Enterprises Limited is a growing pharmaceutical company promoted by Atul Kumar Jain.
The Company was incorporated as 'Fabino Life Sciences Private Limited' on October 27, 2011 with the Registrar of Companies, Delhi and Haryana.
Subsequently, the Company got converted to Public Limited Company and the name of Company was changed to 'Fabino Life Sciences Limited'.
A fresh Certificate of Incorporation was issued on March 21, 2015 by the Registrar of Companies, Delhi. The Company operate in the business of manufacturing, marketing of pharmaceutical, allopathic, herbal, veterinary, and other consumer products like, packing, trading, etc.
The core business is marketing of pharmaceutical formulation & products in domestic market through its own distribution network and sales force under own brand name, getting Ayurvedic formulations manufactured through loan licensing facilities, packing, labeling etc.

About Phaarmasia Ltd

Incorporated in 1981, Phaarmasia Limited (unit-I) is the part of the Maneesh Pharmaceutical Limited, with its headquarters and marketing office in Mumbai.
M/s Phaarmasia Limited Unit-II was established in 1993-94.
The Company is engaged in manufacturing and marketing of Oral contraceptive tablets' with various therapeutic dosage combinations along with iron tablets for Ministry of Health & Family Welfare and for Exports. The plant is situated in a hygienic environment; free from dust, smoke, chemical & biological emission.
Phaarmasia Ltd. Is an independent State-of-the-art-manufacturing unit having manufacturing facility of international standards with manufacturing capacity of more than 30 million units per annum. During the year 2000, the company became a Sick Industrial Company under SICA and therefore the same was referred to the BIFR.

FAQs for the comparison of Fabino Enterprises Ltd and Phaarmasia Ltd

Which company has a larger market capitalization, Fabino Enterprises Ltd or Phaarmasia Ltd?

Market cap of Fabino Enterprises Ltd is 4 Cr while Market cap of Phaarmasia Ltd is 67 Cr

What are the key factors driving the stock performance of Fabino Enterprises Ltd and Phaarmasia Ltd?

The stock performance of Fabino Enterprises Ltd and Phaarmasia Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Fabino Enterprises Ltd and Phaarmasia Ltd?

As of May 5, 2026, the Fabino Enterprises Ltd stock price is INR ₹20.31. On the other hand, Phaarmasia Ltd stock price is INR ₹98.16.

How do dividend payouts of Fabino Enterprises Ltd and Phaarmasia Ltd compare?

To compare the dividend payouts of Fabino Enterprises Ltd and Phaarmasia Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.